KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Shares Outstanding (Diluted Average) (2020 - 2026)

Pacific Biosciences Of California has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $300.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 4.02% year-over-year to $300.0 million; the TTM value through Dec 2025 reached $300.0 million, up 4.02%, while the annual FY2025 figure was $300.0 million, 4.02% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $300.0 million at Pacific Biosciences Of California, roughly flat from $299.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $300.2 million in Q2 2025 and troughed at $196.7 million in Q2 2021.
  • A 5-year average of $255.0 million and a median of $254.3 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 28.36% in 2021 and later rose 4.02% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $204.1 million in 2021, then grew by 10.0% to $224.6 million in 2022, then rose by 12.95% to $253.6 million in 2023, then rose by 13.7% to $288.4 million in 2024, then rose by 4.02% to $300.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for PACB at $300.0 million in Q4 2025, $299.3 million in Q3 2025, and $300.2 million in Q2 2025.